全文获取类型
收费全文 | 17251篇 |
免费 | 2313篇 |
国内免费 | 9273篇 |
出版年
2024年 | 204篇 |
2023年 | 609篇 |
2022年 | 949篇 |
2021年 | 1153篇 |
2020年 | 991篇 |
2019年 | 1138篇 |
2018年 | 785篇 |
2017年 | 767篇 |
2016年 | 800篇 |
2015年 | 1181篇 |
2014年 | 1556篇 |
2013年 | 1353篇 |
2012年 | 1811篇 |
2011年 | 1814篇 |
2010年 | 1421篇 |
2009年 | 1531篇 |
2008年 | 1621篇 |
2007年 | 1510篇 |
2006年 | 1413篇 |
2005年 | 1164篇 |
2004年 | 869篇 |
2003年 | 766篇 |
2002年 | 708篇 |
2001年 | 629篇 |
2000年 | 553篇 |
1999年 | 409篇 |
1998年 | 165篇 |
1997年 | 138篇 |
1996年 | 118篇 |
1995年 | 97篇 |
1994年 | 87篇 |
1993年 | 94篇 |
1992年 | 56篇 |
1991年 | 61篇 |
1990年 | 40篇 |
1989年 | 28篇 |
1988年 | 29篇 |
1987年 | 19篇 |
1986年 | 26篇 |
1985年 | 35篇 |
1984年 | 15篇 |
1983年 | 10篇 |
1982年 | 34篇 |
1981年 | 9篇 |
1980年 | 5篇 |
1965年 | 5篇 |
1964年 | 5篇 |
1958年 | 5篇 |
1955年 | 5篇 |
1950年 | 7篇 |
排序方式: 共有10000条查询结果,搜索用时 46 毫秒
131.
132.
Regenerative medicine is a burgeoning field that is important to combat challenging diseases and functional impairments. Compared with traditional cell therapies with evident shortcomings (e.g., cell suspension injection or tissue engineering with scaffolds), scaffold-free cell sheet technology enables transplanted cells to be grafted and fully maintain their viability on target sites. Clinical and experimental studies have advanced the application of cell sheet technology to numerous tissues and organs (e.g., liver, cornea and bone). However, previous reviews have failed to discuss vital aspects of this rapidly developing technology, and many new challenges are gradually emerging. This review aims to provide a comprehensive introduction to cell sheet technology from cell selection to the ultimate applications of cell sheets, and challenges and future visions are also described. 相似文献
133.
134.
135.
136.
137.
138.
Tai‐An Chiang Yu‐Lin Yang Ya‐Ying Yang Min‐Hsiu Hu Pei‐Fen Wu Shu‐Fen Liu Ruay‐Ming Huang Tung‐Nan Liao Chien‐Ya Hung Tsung‐Jen Hung Tao‐Chen Lee 《Journal of cellular biochemistry》2010,109(4):663-671
Hyperosmolarity plays an essential role in the pathogenesis of diabetic tubular fibrosis. However, the mechanism of the involvement of hyperosmolarity remains unclear. In this study, mannitol was used to evaluate the effects of hyperosmolarity on a renal distal tubule cell line (MDCK). We investigated transforming growth factor‐β receptors and their downstream fibrogenic signal proteins. We show that hyperosmolarity significantly enhances the susceptibility to exogenous transforming growth factor (TGF)‐β1, as mannitol (27.5 mM) significantly enhanced the TGF‐β1‐induced increase in fibronectin levels compared with control experiments (5.5 mM). Specifically, hyperosmolarity induced tyrosine phosphorylation on TGF‐β RII at 336 residues in a time (0–24 h) and dose (5.5–38.5 mM) dependent manner. In addition, hyperosmolarity increased the level of TGF‐β RI in a dose‐ and time‐course dependent manner. These observations may be closely related to decreased catabolism of TGF‐β RI. Hyperosmolarity significantly downregulated the expression of an inhibitory Smad (Smad7), decreased the level of Smurf 1, and reduced ubiquitination of TGF‐β RI. In addition, through the use of cycloheximide and the proteasome inhibitor MG132, we showed that hyperosmolarity significantly increased the half‐life and inhibited the protein level of TGF‐β RI by polyubiquitination and proteasomal degradation. Taken together, our data suggest that hyperosmolarity enhances cellular susceptibility to renal tubular fibrosis by activating the Smad7 pathway and increasing the stability of type I TGF‐β receptors by retarding proteasomal degradation of TGF‐β RI. This study clarifies the mechanism underlying hyperosmotic‐induced renal fibrosis in renal distal tubule cells. J. Cell. Biochem. 109: 663–671, 2010. © 2010 Wiley‐Liss, Inc. 相似文献
139.
Pei Dong Jessica Flores Kristine Pelton Keith R. Solomon 《Journal of cellular biochemistry》2010,111(5):1367-1374
Cholesterol is essential in establishing most functional animal cell membranes; cells cannot grow or proliferate in the absence of sufficient cholesterol. Consequently, almost every cell, tissue, and animal tightly regulates cholesterol homeostasis, including complex mechanisms of synthesis, transport, uptake, and disposition of cholesterol molecules. We hypothesize that cellular recognition of cholesterol insufficiency causes cell cycle arrest in order to avoid a catastrophic failure in membrane synthesis. Here, we demonstrate using unbiased proteomics and standard biochemistry that cholesterol insufficiency causes upregulation of prohibitin, an inhibitor of cell cycle progression, through activation of a cholesterol‐responsive promoter element. We also demonstrate that prohibitin protects cells from apoptosis caused by cholesterol insufficiency. This is the first study tying cholesterol homeostasis to a specific cell cycle regulator that inhibits apoptosis. J. Cell. Biochem. 111: 1367–1374, 2010. © 2010 Wiley‐Liss, Inc. 相似文献
140.
Surfactin作为一种绿色生物表面活性素在多种领域均有潜在的应用价值,但是在生产过程中存在着泡沫难以控制的问题,阻碍了其实现工业化生产。因此在7L发酵罐水平探究了适合surfactin工业化生产的最佳发酵策略。研究结果表明,过量添加消泡剂会对微生物的生长造成不利影响而且会增加生产成本,以有机硅和大豆油为消泡剂时surfactin产量分别为1.42g/L和1.96g/L。通过改进发酵罐采用泡沫分离的发酵策略,不仅可以经济有效地解决泡沫难以控制的问题,而且可以实现surfactin的原位分离,surfactin产量为2.39g/L;基于泡沫分离式发酵,控制pH=7后surfactin产量提高至3.45g/L;又进一步通过控制DO≥20%后产量提高至5.07g/L。最后,将泡沫分离耦合pH、溶解氧控制及恒速补料,控制pH=7、DO≥20%、恒速流加速度1.39ml/min,可以将surfactin产量显著提高至6.04g/L,与添加消泡剂相比,产量提高了4.25倍。以上结果为surfactin的工业化生产提供了依据。 相似文献